戻る Agenda
Session 5. Clinical Research Regulations : Critical Aspects that Impacts Clinical Research Practices
Session Chair(s)
Ellyne Setiawan, MPHARM
Head of Research & Development Quality (Asia Pacific),
Daiichi Sankyo Singapore Pte. Ltd., Singapore
Senthil Sockalingam
Head of Medical Affairs, APAC
BeiGene, Singapore
Speaker(s)
Overview of ICH GCP E6 (R3) Renovation
Peter Twomey, MA, MPHARM
European Medicines Agency, Netherlands
Head of Inspections
ICH E6 R3 DCT – A Clinical Trial Odyssey
Cathy Dove
DQS, United Kingdom
Director Quality & Risk Management
Regulatory Landscape of Decentralised Clinical Trials in Asia Pacific
Sandy Chan
Johnson & Johnson, Singapore
Associate Director, Regulatory Policy & Intelligence Lead- Asia Pacific
Rosemarie Corrigan
Global Quality Worldwide Clinical Trials, United Kingdom
Executive Vice President
Xing Li, MSC
Deep Intelligent Pharma ( Singapore) private limited, Singapore
Chief Scientific officer
Sharon Chen
AlphaLife Sciences, United States
Founder and CEO